Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity

被引:90
作者
De Bruyn, Tom [1 ]
Chatterjee, Sagnik [1 ]
Fattah, Sarinj [1 ]
Keemink, Janneke [1 ]
Nicolai, Johan [1 ]
Augustijns, Patrick [1 ]
Annaert, Pieter [1 ]
机构
[1] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, B-3000 Louvain, Belgium
关键词
drug clearance prediction; drug-drug interaction; drug-induced liver injury; hepatocyte; hepatotoxicity; sandwich culture; SALT EXPORT PUMP; PRIMARY RAT HEPATOCYTES; CRYOPRESERVED HUMAN HEPATOCYTES; HIV PROTEASE INHIBITORS; BILE-ACID TRANSPORT; METABOLIZING ENZYME-ACTIVITIES; EVALUATE BILIARY-EXCRETION; NUCLEAR FACTOR 4-ALPHA; COLLAGEN GEL SANDWICH; EXTRACELLULAR-MATRIX;
D O I
10.1517/17425255.2013.773973
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: The sandwich-cultured hepatocyte (SCH) model has become an invaluable in vitro tool for studying hepatic drug transport, metabolism, biliary excretion and toxicity. The relevant expression of many hepatocyte-specific functions together with the in vivo-like morphology favor SCHs over other preclinical models for evaluating hepatobiliary drug disposition and drug-induced hepatotoxicity. Areas covered: In this review, the authors highlight recommended procedures required for reproducibly culturing hepatocytes in sandwich configuration. It also provides an overview of the SCH model characteristics as a function of culture time. Lastly, the article presents a summary of the most prominent applications of the SCH model, including hepatic drug clearance prediction, drug-drug interaction potential and drug-induced hepatotoxicity. Expert opinion: When human (cryopreserved) hepatocytes are used to establish sandwich cultures, the model appears particularly valuable to quantitatively investigate clinically relevant mechanisms related to in vivo hepatobiliary drug disposition and hepatotoxicity. Nonetheless, the SCH model would largely benefit from better insight into the fundamental cell signaling mechanisms that are critical for long-term in vitro maintenance of the hepatocytic phenotype. Studies systematically exploring improved cell culture conditions (e.g., co-cultures or extracellular matrix modifications), as well as in vitro work identifying key transcription factors involved in hepatocyte differentiation are currently emerging.
引用
收藏
页码:589 / 616
页数:28
相关论文
共 171 条
  • [1] In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors in sandwich-cultured rat hepatocytes: Comparison with in vivo biliary clearance
    Abe, Koji
    Bridges, Arlene S.
    Yue, Wei
    Brouwer, Kim L. R.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 326 (03) : 983 - 990
  • [2] Use of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase Inhibitors
    Abe, Koji
    Bridges, Arlene S.
    Brouwer, Kim L. R.
    [J]. DRUG METABOLISM AND DISPOSITION, 2009, 37 (03) : 447 - 452
  • [3] Ah YM, 2008, DRUG METAB REV, V40, P511, DOI [10.1080/03602530802341133, 10.1080/03602530802341133 ]
  • [4] Alexandre E., 2002, Cell and Tissue Banking, V3, P223
  • [5] Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes
    Annaert, PP
    Brouwer, KLR
    [J]. DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) : 388 - 394
  • [6] Annaert PP, 2001, DRUG METAB DISPOS, V29, P1277
  • [7] [Anonymous], 2012, Guideline on the Investigation of Drug Interactions
  • [8] [Anonymous], 2012, GUIDANCE DR IN PRESS
  • [9] An In Vitro Assay to Assess Transporter-Based Cholestatic Hepatotoxicity Using Sandwich-Cultured Rat Hepatocytes
    Ansede, John H.
    Smith, William R.
    Perry, Cassandra H.
    St Claire, Robert L., III
    Brouwer, Kenneth R.
    [J]. DRUG METABOLISM AND DISPOSITION, 2010, 38 (02) : 276 - 280
  • [10] Primary porcine enterocyte and hepatocyte cultures to study drug oxidation reactions
    Bader, A
    Hansen, T
    Kirchner, G
    Allmeling, C
    Haverich, A
    Borlak, JT
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (02) : 331 - 342